NO20021692L
Purine derivatives
Abstract
The invention relates to a compound as formula (I), and pharmaceutical acceptable salt thereof, and a preparation method, for which the compound, the compound can personhood are A2a receptor agonist.
Term
No projected expiry on record.
- Priority
- Filed and published
- Today
61 members in 50 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 9924363 | United Kingdom | A | |
| 9924363 | United Kingdom | A | |
| 0001444 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 0001444 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 0001444 | – | – | – |
| 9924363 | – | – | – |
| GB19990024363 | – | – | – |
| WO2000IB01444 | – | – | – |
Members61
| Document | Office | Kind | |
|---|---|---|---|
| GB9924363D0 | United Kingdom | D0 | |
| CA2387531A1 | Canada | A1 | |
| DZ3159A1 | Algeria | A1 | |
| WO0127130A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7548800A | Australia | A | |
| UY26397A1 | Uruguay | A1 | |
| HN2000000204A | Honduras | A | |
| PE20010755A1 | Peru | A1 | |
| IS6165A | Iceland | A | |
| SV2002000198A | El Salvador | A | |
| PA8503501A1 | Panama | A1 | |
| US6350735B1 | United States of America | B1 | |
| BR0011776A | Brazil | A | |
| GT200000172A | Guatemala | A | |
| NO20021692D0 | Norway | D0 | |
| NO20021692LThis record | Norway | L | |
| KR20020037774A | Republic of Korea | A | |
| ECSP003712A | Ecuador | A | |
| CN1358192A | China | A | |
| EP1220863A1 | European Patent Office (EPO) | A1 | |
| IL146342D0 | Israel | D0 | |
| AR023275A1 | Argentina | A1 | |
| MXPA02003812A | Mexico | A | |
| TR200200985T2 | Türkiye | T2 | |
| EA200101107A1 | Eurasian Patent Organization (EAPO) | A1 | |
| BG106569A | Bulgaria | A | |
| HK1047110A1 | Hong Kong, China | A1 | |
| CO5251399A1 | Colombia | A1 | |
| HU0203483A2 | Hungary | A2 | |
| HUP0203483A2 | Hungary | A2 | |
| JP2003511459A | Japan | A | |
| EP1220863B1 | European Patent Office (EPO) | B1 | |
| CZ20021223A3 | Czechia | A3 | |
| AT238336T | Austria | T | |
| ATE238336T1 | Austria | T1 | |
| DE60002356D1 | Germany | D1 | |
| SK4842002A3 | Slovakia | A3 | |
| EE200200193A | Estonia | A | |
| ZA200202849B | South Africa | B | |
| PT1220863E | Portugal | E | |
| DK1220863T3 | Denmark | T3 | |
| NZ515323A | New Zealand | A | |
| SI1220863T1 | Slovenia | T1 | |
| ES2193990T3 | Spain | T3 | |
| AU768308B2 | Australia | B2 | |
| CR6584A | Costa Rica | A | |
| DE60002356T2 | Germany | T2 | |
| PL354932A1 | Poland | A1 | |
| CN1151167C | China | C | |
| UA66945C2 | Ukraine | C2 | |
| EA004655B1 | Eurasian Patent Organization (EAPO) | B1 | |
| GEP20043269B | Georgia | B | |
| YU88901A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| MA26828A1 | Morocco | A1 | |
| HK1047110B | Hong Kong, China | B | |
| AP1442A | African Regional Intellectual Property Organization (ARIPO) | A | |
| TNSN00202A1 | Tunisia | A1 | |
| OA12059A | African Intellectual Property Organization (OAPI) | A | |
| CA2387531C | Canada | C | |
| JP3994007B2 | Japan | B2 | |
| MY136242A | Malaysia | A |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Withdrawal, rejection or dismissal of laid open patent applicationFC2A | FC2A |
Numbers
- Publication, DOCDB
- 20021692
- Publication, EPODOC
- NO20021692L
- Application
- 1692
- Application, DOCDB
- 20021692
- Application, EPODOC
- NO20020001692
Titles2
- Norwegian
- Purinderivater
- English
- purine derivatives
Classification
- CPC, 23
- C07H19/16
- C07D473/34
- A61P1/04
- A61P11/00
- A61P11/02
- A61P11/06
- A61P15/10
- A61P17/00
- A61P17/06
- A61P19/02
- A61P25/00
- A61P25/08
- A61P25/18
- A61P29/00
- A61P31/04
- A61P37/08
- A61P43/00
- A61P9/00
- A61P9/10
- A61P9/12
- A61P3/10
- A61K31/52
- C07H19/167
- IPC, 18
- A61K31 52
- A61K31 70
- C07D473 34
- A61P1 04
- A61P3 10
- A61P9 00
- A61P9 10
- A61P11 00
- A61P11 02
- A61P11 06
- A61P15 10
- A61P17 06
- A61P19 02
- A61P25 08
- A61P29 00
- A61P37 08
- C07H19 16
- C07H19 167